-
The Affordable Care Act’s Impact on Access to Cancer CareA study at the AACR Cancer Health Disparities Conference found more people got quality cancer care after the ACA went into effect.
by Cancer Research Catalyst
-
Understanding the Federal Rule on Breast Tissue Density ReportsScreening mammography reports will include breast density and an explanation in common language.
by Sandra Gordon
-
From the Editor-in-Chief
Innovative Therapy Takes a BiTE Out of CancerBispecific T-cell engagers (BiTEs) bring immune cells close enough to cancer cells to destroy them.
by William G. Nelson, MD, PhD
-
Forward Look
The Cost of Dental Side EffectsHead and neck cancer survivors often face significant costs for treatments not covered by health insurance.
by Kris Conner
-
Forward Look
Shining a Spotlight on Health-related Social NeedsHealth care teams should ask about support needs including transportation, housing, food and financial security.
by Darcy Lewis
-
Forward Look
A More Targeted PARP InhibitorEarly research suggests treatment could have higher potency and less toxicity for people with BRCA-related cancers.
by Marci A. Landsmann
-
Forward Look
Immunotherapy Improves Survival in Early-stage Kidney CancerPeople who have surgery to remove kidney cancer that has a high chance of recurrence must weigh benefits and risks of additional treatment.
by Christina Szalinski
-
Breast Cancer: Making Treatment DecisionsWith additional treatment options and an emphasis on reducing side effects, patients with breast cancer have more decisions to make than ever before.
by Natalie Slivinski
-
Patients as Research PartnersNew platforms allow patients to share their clinical data and tumor tissue no matter where they live, offering everyone a chance to participate in research.
by Erin O'Donnell
-
Healthy Habits
Nature’s RemedyGinger can help reduce nausea and vomiting after chemotherapy.
by Anne Danahy
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
